# Mycosis Culture Collection From Dermatological Isolated

> **NCT05482763** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Rome Tor Vergata** · enrollment: 200 (estimated)

## Conditions studied

- Onychomycosis
- Resistant Infection
- Nail Diseases

## Interventions

- **DRUG:** Terbinafine Topical Gel
- **DRUG:** Itraconazole 200 mg
- **DRUG:** Terbinafine 250 mg
- **DRUG:** Ciclopirox Topical Gel
- **DRUG:** Amorolfine 50 MG/ML

## Key facts

- **NCT ID:** NCT05482763
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-20
- **Primary completion:** 2025-07-20
- **Final completion:** 2025-12-25
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05482763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05482763, "Mycosis Culture Collection From Dermatological Isolated". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05482763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*